Unum Therapeutics Inc. | 200 Cambridge Park Drive Suite 3100 | Cambridge, MA 02140  USA

Tel. +1.617.945.5576 | Email: info@unumrx.com

  • LinkedIn - White Circle
  • Twitter - White Circle

© Copyright 2014-2019 Unum Therapeutics

December 01, 2014

Unum Therapeutics Announces Start of First Phase I Clinical Trial of Cellular Immunotherapy Targeting CD20+ Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma

Unum Therapeutics Announces Start of First Phase I Clinical Trial of Cellular Immunotherapy Targeting CD20+ Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma

December 01, 2014

With Souped-Up Rituxan, Unum Plots First Foray Into T-Cell Therapy

With Souped-Up Rituxan, Unum Plots First Foray Into T-Cell Therapy

October 21, 2014

Fidelity Biosciences and Atlas Venture Lead $12 Million Series A Funding to Launch Unum Therapeutics, a New Cellular Immunotherapy Company

Fidelity Biosciences and Atlas Venture Lead $12 Million Series A Funding to Launch Unum Therapeutics, a New Cellular Immunotherapy Company

October 21, 2014

Sanofi-Genzyme Joins $12M Round for T-Cell Therapy Startup, Unum

Sanofi-Genzyme Joins $12M Round for T-Cell Therapy Startup, Unum

October 21, 2014

Meet Unum, a new immunotherapy biotech with Fidelity, Atlas and Sanofi in its corner

Meet Unum, a new immunotherapy biotech with Fidelity, Atlas and Sanofi in its corner

Please reload